Global  

Regeneron says its COVID-19 drug cut patient visits

Video Credit: Reuters - Politics - Duration: 01:56s - Published
Regeneron says its COVID-19 drug cut patient visits

Regeneron says its COVID-19 drug cut patient visits

Regeneron said on Wednesday its coronavirus antibody cocktail - used to treat U.S. President Donald Trump - significantly reduced medical visits in a trial of nearly 800 patients.

Gloria Tso reports.

Drugmaker Regeneron said Wednesday its COVID-19 antibody cocktail, used to treat U.S. President Donald Trump, significantly cut medical visits in a trial of nearly 800 patients.

Regeneron said patients given the treatment, called REGN-COV2, made around 57% fewer COVID-19-related medical visits than those given a placebo over a period of 29 days.

The drop was around 72% in patients with one or more risk factors such as obesity or an immunocompromised status.

Regeneron's drug is a cocktail of two monoclonal antibodies, which are manufactured copies of antibodies.

They're one of the main weapons the immune system generates to fight infections.

Trump has credited the Regeneron therapy for his COVID-19 recovery.

"But they gave me Regeneron and it was like, unbelievable.

I felt good.

Immediately.

I felt as good three days ago as I do now." He's said he would push for emergency use authorization (EUA) of that treatment and others like it, and that he wanted to provide it to Americans at no cost.

However, Regeneron said earlier this month it only had a limited amount of doses of its therapy -- just 50,000 ready for distribution.

The U.S. government had agreed to buy up to 300,000 doses for $450 million in June.

In September Regeneron also released early data from the trial showing the treatment reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients.

The company says the new data confirms the initial findings, and that they shared it with the U.S. Food and Drug Administration after filing for an EUA earlier this month.

Eli Lilly, which makes a similar drug, has also filed for the authorization, and signed a contract Wednesday to provide 300,000 doses of its treatment to the U.S. government.




You Might Like


💡 One News Page Knowledge: Other News Mentions

Regeneron Pharmaceuticals Regeneron Pharmaceuticals American biotechnology company

Eli Lilly pauses trial of antibody drug over safety concern [Video]

Eli Lilly pauses trial of antibody drug over safety concern

Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety concern. This report produced by Jillian Kitchener.

Credit: Reuters - Politics    Duration: 01:12Published
Trump may return to campaign trail Saturday [Video]

Trump may return to campaign trail Saturday

Republican President Donald Trump on Friday prepared to return to the campaign trail with a pair of weekend rallies after his COVID-19 diagnosis sidelined him for a week in the race against Democratic nominee Joe Biden for the White House. Gloria Tso reports.

Credit: Reuters - Politics    Duration: 01:35Published
Trump says catching COVID-19 a 'blessing from God' [Video]

Trump says catching COVID-19 a 'blessing from God'

U.S. President Donald Trump declared that catching the coronavirus was a "blessing from God" that exposed him to experimental treatments he vowed would become free for all Americans, in a video address released on Wednesday. Libby Hogan reports.

Credit: Reuters - Politics    Duration: 01:54Published

Donald Trump Donald Trump 45th president of the United States

US election: Did Rudy Giuliani fart at Michigan election fraud hearing?

Another week, another instance of Rudy Giuliani making headlines for less-than-flattering reasons.This time, the former New York Mayor and current Trump lawyer..
New Zealand Herald

Nissan follows GM in ditching Trump’s effort to overturn California’s pollution rules

Photo by Erin Schaff - Pool/Getty Images

President Donald Trump’s effort to overturn California’s ability to set fuel efficiency rules just lost..

The Verge

Trump's niece: Pres. 'cruel and traitorous'

President Trump's estranged niece, says his insistence that he won the 2020 election is borne of his belief that he always deserves to win and "cheat and steal"..
USATODAY.com

Supreme Court will hear Trump administration defend controversial Medicaid work requirements

Forcing low-income people to work or prepare for employment in exchange for health coverage is an experiment that's been tried in only three states.

USATODAY.com

Trump voter fraud claims impact Georgia run-offs

President Donald Trump's baseless claims of voter fraud will either help or hurt Republicans effort to retain the U.S. Senate, as the president visits Georgia to..
USATODAY.com

Emergency use authorization

Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine [Video]

Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine

Pfizer announced Friday that it would submit a request to the FDA Friday for its COVID-19 vaccine to be granted Emergency Use Authorization.

Credit: ABC Action News    Duration: 01:51Published

REGN-COV2 REGN-COV2 Experimental drug (antibody cocktail against SARS-CoV-2) developed by Regeneron


Related videos from verified sources

Antibody Drug Regeneron Enters Clinical Trials At UM [Video]

Antibody Drug Regeneron Enters Clinical Trials At UM

CBS4's Steve Goldstein reports it's the same drug given to President Donald Trump when he tested positive for COVID-19.

Credit: CBS4 Miami     Duration: 02:22Published
Regeneron Seeks FDA's Emergency Use Authorization For COVID-19 Antibody Treatment Given To President Trump [Video]

Regeneron Seeks FDA's Emergency Use Authorization For COVID-19 Antibody Treatment Given To President Trump

Pres. Donald Trump credits drug maker Regeneron's treatment for relieving his COVID-19 symptoms. But, what is it, and how might you get it? CBS2's Meg Baker reports.

Credit: CBS 2 New York     Duration: 02:15Published